E tusa ai ma le National Medical Products Administration's Announcement Numera 103 o le 2024, o le faʻaulufale mai, faʻatau atu, ma le faʻaaogaina o le UCB Pharma SA Levetiracetam Injection Concentrate ua toe faʻaauau.
Faʻavae i luga o faʻaiʻuga o suʻesuʻega e le o ni nofoaga i fafo, na tuʻuina atu e le National Medical Products Administration (NMPA) le Faʻasalalauga Numera 67 i le aso 22 o Aokuso, 2022, ma filifili ai e taofi le faʻaulufaleina mai, faʻatau atu, ma le faʻaaogaina o le UCB Pharma SA's Levetiracetam Injection Concentrate ...
va'ai fa'amatalaga